Recent Finacing
Recent Raise
Inivata provides ctDNA liquid-biopsy assays (InVision platform, InVisionFirst‑Lung, RaDaR) for noninvasive tumor mutation profiling, MRD detection, and serves pharma; operates CLIA/CAP lab in RTP and R&D in Cambridge.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Inivata.
